KSA National Immunization Schedule
KSA National Immunization Schedule
VACCINE |
CONTRAINDICATIONS TO COMMONLY USED VACCINES | |||||
|---|---|---|---|---|---|---|
| Influenza | • Severe allergic reaction (e.g., anaphylaxis) after previous dose of any influenza
vaccine. • Severe allergic reaction (e.g., anaphylaxis) to any vaccine component (excluding egg) |
|||||
| DTaP | • Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine
component • Encephalopathy (e.g., coma, decreased level of consciousness, prolonged seizures) not attributable to another identifiable cause within 7 days of administration of previous dose of DTaP |
|||||
| Hep.B | • Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine component including yeast | |||||
| Hep.A | • Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine component3 including neomycin | |||||
| Hib |
• Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a
vaccine component3 •For ActHib only: History of severe allergic reaction to dry natural latex •Less than age 6 weeks |
|||||
| IPV | • Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine component | |||||
| HPV |
• Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a
vaccine component • Pregnancy: HPV vaccination not recommended. |
|||||
| MenACWY |
• Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a
vaccine component3 • For MenACWY-D and Men ACWY-CRM only: severe allergic reaction to any diphtheria toxoid– or CRM197–containing vaccine • For MenACWY-TT only: severe allergic reaction to a tetanus toxoidcontaining vaccine |
|||||
| Rota |
• Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a
vaccine component3 • Severe combined immunodeficiency (SCID) • History of intussusception |
|||||
| PCV |
• Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine
component • Severe allergic reaction (e.g., anaphylaxis) to any diphtheria-toxoid-containing vaccine or its component |
|||||
| PPV23 | • Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine component | |||||
| MMR |
• Severe immunodeficiency (e.g., hematologic and solid tumors, receipt of
chemotherapy, congenital immunodeficiency, long-term immunosuppressive
therapy or patients with HIV infection who are severely immunocompromised) • Pregnancy • Family history of altered immunocompetence, unless verified clinically or by laboratory testing as immunocompetent |
|||||
| Varicella |
• Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine
component3 • Severe immunodeficiency (e.g., hematologic and solid tumors, receipt of chemotherapy, congenital immunodeficiency, long-term immunosuppressive therapy or patients with HIV infection who are severely immunocompromised) • Pregnancy • Family history of altered immunocompetence, unless verified clinically or by laboratory testing as immunocompetent |
|||||
© 2023 Vaccine Information. Powered by Advances&More. All Rights Reserved.